169 related articles for article (PubMed ID: 38082365)
1. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression.
Xu H; Li YF; Yi XY; Zheng XN; Yang Y; Wang Y; Liao DZ; Zhang JP; Tan P; Xiong XY; Jin X; Gong LN; Qiu S; Cao DH; Li H; Wei Q; Yang L; Ai JZ
Mil Med Res; 2023 Dec; 10(1):64. PubMed ID: 38082365
[TBL] [Abstract][Full Text] [Related]
2. ADP-dependent glucokinase: the ancient, archaeal key to prostate cancer.
Kamiński MM
Mil Med Res; 2024 Feb; 11(1):10. PubMed ID: 38342920
[No Abstract] [Full Text] [Related]
3. Expression and role in glycolysis of human ADP-dependent glucokinase.
Richter S; Richter JP; Mehta SY; Gribble AM; Sutherland-Smith AJ; Stowell KM; Print CG; Ronimus RS; Wilson WR
Mol Cell Biochem; 2012 May; 364(1-2):131-45. PubMed ID: 22219026
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of ADP-dependent glucokinase in prostate cancer.
Zhang X
Mil Med Res; 2024 Feb; 11(1):15. PubMed ID: 38409104
[No Abstract] [Full Text] [Related]
5. Zinc finger nuclease mediated knockout of ADP-dependent glucokinase in cancer cell lines: effects on cell survival and mitochondrial oxidative metabolism.
Richter S; Morrison S; Connor T; Su J; Print CG; Ronimus RS; McGee SL; Wilson WR
PLoS One; 2013; 8(6):e65267. PubMed ID: 23799003
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for ADP-dependent glucokinase inhibition by 8-bromo-substituted adenosine nucleotide.
Grudnik P; Kamiński MM; Rembacz KP; Kuśka K; Madej M; Potempa J; Dawidowski M; Dubin G
J Biol Chem; 2018 Jul; 293(28):11088-11099. PubMed ID: 29784881
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
8. The Structural and Functional Characterization of Mammalian ADP-dependent Glucokinase.
Richter JP; Goroncy AK; Ronimus RS; Sutherland-Smith AJ
J Biol Chem; 2016 Feb; 291(8):3694-704. PubMed ID: 26555263
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
10. ADP-dependent glucokinase as a novel onco-target for haematological malignancies.
Tandon A; Birkenhagen J; Nagalla D; Kölker S; Sauer SW
Sci Rep; 2020 Aug; 10(1):13584. PubMed ID: 32788680
[TBL] [Abstract][Full Text] [Related]
11. ADP-dependent glucokinase regulates energy metabolism via ER-localized glucose sensing.
Imle R; Wang BT; Stützenberger N; Birkenhagen J; Tandon A; Carl M; Himmelreich N; Thiel C; Gröne HJ; Poschet G; Völkers M; Gülow K; Schröder A; Carillo S; Mittermayr S; Bones J; Kamiński MM; Kölker S; Sauer SW
Sci Rep; 2019 Oct; 9(1):14248. PubMed ID: 31582762
[TBL] [Abstract][Full Text] [Related]
12. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
[TBL] [Abstract][Full Text] [Related]
13. T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation.
Kamiński MM; Sauer SW; Kamiński M; Opp S; Ruppert T; Grigaravičius P; Grudnik P; Gröne HJ; Krammer PH; Gülow K
Cell Rep; 2012 Nov; 2(5):1300-15. PubMed ID: 23168256
[TBL] [Abstract][Full Text] [Related]
14. METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis.
Liu J; Yuan JF; Wang YZ
Exp Cell Res; 2022 Jul; 416(1):113149. PubMed ID: 35405116
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of ADP-dependent glucokinase from Methanocaldococcus jannaschii in complex with 5-iodotubercidin reveals phosphoryl transfer mechanism.
Tokarz P; Wiśniewska M; Kamiński MM; Dubin G; Grudnik P
Protein Sci; 2018 Mar; 27(3):790-797. PubMed ID: 29352744
[TBL] [Abstract][Full Text] [Related]
16. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling.
Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.
Zheng Y; Jin J; Gao Y; Luo C; Wu X; Liu J
Med Sci Monit; 2020 Jul; 26():e924328. PubMed ID: 32696762
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
[TBL] [Abstract][Full Text] [Related]
19. Targeted metabolomics reveals PFKFB3 as a key target for elemene-mediated inhibition of glycolysis in prostate cancer cells.
Dong XM; Chen L; Wu P; Cheng LH; Wang Y; Yang Y; Zhang Y; Tang WY; Xie T; Zhou JL
Phytomedicine; 2024 Jan; 123():155185. PubMed ID: 38134863
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
